Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antineoplastic agents from plants.

× No keyword cloud information.

11 in total

1. Current trends in the chemoprevention of cancer.

Authors: Fazlul H Sarkar
Journal: Pharm Res Date: 2010-04-17 Impact factor: 4.200

Review 2. The role of plant-derived drugs and herbal medicines in healthcare.

Authors: P A De Smet
Journal: Drugs Date: 1997-12 Impact factor: 9.546

Review 3. Topoisomerase I interactive drugs in children with cancer.

Authors: C F Stewart; W C Zamboni; W R Crom; A Gajjar; R L Heideman; W L Furman; W H Meyer; P J Houghton; C B Pratt
Journal: Invest New Drugs Date: 1996 Impact factor: 3.850

4. New natural products of interest under development at the National Cancer Institute.

Authors: J Douros; M Suffness
Journal: Cancer Chemother Pharmacol Date: 1978 Impact factor: 3.333

5. Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks.

Authors: L J van Warmerdam; J Verweij; J H Schellens; H Rosing; B E Davies; M de Boer-Dennert; R A Maes; J H Beijnen
Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333

6. Plasma pharmacokinetics of lactone and carboxylate forms of 20(S)-camptothecin in anesthetized rats.

Authors: D O Scott; D S Bindra; V J Stella
Journal: Pharm Res Date: 1993-10 Impact factor: 4.200

Review 7. Medicinal plants and cancer chemoprevention.

Authors: Avni G Desai; Ghulam N Qazi; Ramesh K Ganju; Mahmoud El-Tamer; Jaswant Singh; Ajit K Saxena; Yashbir S Bedi; Subhash C Taneja; Hari K Bhat
Journal: Curr Drug Metab Date: 2008-09 Impact factor: 3.731

8. A mechanistic and kinetic study of the E-ring hydrolysis and lactonization of a novel phosphoryloxymethyl prodrug of camptothecin.

Authors: Bradley A Hanson; Richard L Schowen; Valentino J Stella
Journal: Pharm Res Date: 2003-07 Impact factor: 4.200

Review 9. Camptothecins: a review of their chemotherapeutic potential.

Authors: Hulya Ulukan; Peter W Swaan
Journal: Drugs Date: 2002 Impact factor: 9.546

10. Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer.

Authors: C A Jamis-Dow; R W Klecker; G Sarosy; E Reed; J M Collins
Journal: Cancer Chemother Pharmacol Date: 1993 Impact factor: 3.333